Lymphoma

Fifteen-year follow-up from the S0016 trial found over one-third of patients with follicular lymphoma treated with chemoimmunotherapy had no progression.

A personal look at choosing to be a caregiver, the challenges faced, and the lessons learned while supporting a sister through years with cancer.

Ipsen has pulled Tazverik from all markets after a trial found risks of secondary blood cancers, affecting patients with follicular lymphoma and epithelioid sarcoma.

Resilience programs using mindfulness and cognitive behavioral strategies help cancer survivors manage their fear and stress, as well as adjust after treatment.

Living long-term with cancer means learning to live in chapters. There are calm chapters and uncertain ones. Seasons of stability and seasons of intervention.

Overview of nodular sclerosis Hodgkin lymphoma, including diagnosis, staging, treatment options by stage and possible side effects.

FDA removal of an exclusion allows Yescarta use in primary CNS lymphoma, showing safety and strong efficacy in relapsed disease.

In an interview with CURE, Dr. Lakshmi Nayak explains how an FDA label update expands Yescarta access for relapsed or refractory primary CNS lymphoma.

Gratitude didn’t erase my fear, but it gave me something solid to stand on. It became the coping strategy I needed.

FDA accepted a new drug application for tirabrutinib in relapsed or refractory PCNSL.

Five years ago, I finished treatment and was determined to be no evidence of disease. Until my most recent CT scan, there’s been no sign of recurrence.

Six-time cancer survivor encourages patients to trust doctors, lean on support, and save energy for moving forward instead of fear.

Riozzi Bodine shares how her daughter’s diagnosis inspired the launch of a foundation offering cold caps, wigs and caregiver support.

Most people think of anniversaries as happy things. But there are other anniversaries that commemorate less pleasant events. Some anniversaries are a mix of pleasant and unpleasant.

Hodgkin lymphoma is a cancer of the lymphatic system, which includes lymph nodes, the spleen and immune cells that help the body fight infection.

FDA expands access to CAR-T cell therapy for patients with relapsed or refractory PCNSL.

Losing my cat after years alongside my cancer journey reminded me how much his presence eased stress, anxiety and treatment days.

An expert explains FDA-approved Lymphir for relapsed or refractory CTCL, noting 36% response rate, manageable side effects and fast relief from itching.

Kim Johnson shares her experience losing her sister to cancer, offering guidance for those grieving and for the people supporting them.

The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma.

After five years in remission, a scan shows a small anomaly that might be recurrence, or it can show nothing, leaving a tense week before my oncologist visit.

Outpatient CD19 CAR-NK plus rituximab led to complete remissions up to 15 months in patients with Waldenström Non-Hodgkin lymphoma.

I have lived with both depression and cancer and know that illness, visible or not, ebbs and flows; canceled plans can reflect health limits, not rejection

Patients with relapsed/refractory diffuse large B-cell lymphoma who received Epkinly alone experienced an improvement in progression-free survival.

Now that I have been living with my chronic cancer for 16 and a half years, I’ve been reflecting on how my attitude has changed over time.